DEFECTIVE GLYCINE CLEAVAGE SYSTEM IN NON-KETOTIC HYPERGLYCINEMIA - OCCURRENCE OF A LESS ACTIVE GLYCINE DECARBOXYLASE AND AN ABNORMAL AMINOMETHYL CARRIER PROTEIN
DEFECTIVE GLYCINE CLEAVAGE SYSTEM IN NON-KETOTIC HYPERGLYCINEMIA - OCCURRENCE OF A LESS ACTIVE GLYCINE DECARBOXYLASE AND AN ABNORMAL AMINOMETHYL CARRIER PROTEIN
复制标题
DOI:
10.1172/jci110284
复制
发表时间:
1981-01-01
影响因子:
15.9
通讯作者:
NYHAN, WL
中科院分区:
文献类型:
--
作者:
HIRAGA, K;KOCHI, H;NYHAN, WL
The activities of the glycine cleavage system in the liver and brain of a patient with nonketotic hyperglycinemia were extremely low compared with those of control human liver and brain. The activities of glycine decarboxylase (P-protein) and the aminomethyl carrier protein (H-protein), 2 of the 4 protein components of the glycine cleavage system, were considerably reduced in both the liver and brain; the extent of reduction was greater in the H-protein. The activity of the T-protein was normal. Purified H-protein from the patient did not react with lipoamide dehydrogenase, and titration of thiol groups with [2,3-14C]N-ethylmaleimide suggested that this H-protein is devoid of lipoic acid. This structural abnormality in the H-protein is considered to constitute the primary molecular lesion in this patient with nonketotic hyperglycinemia. Immunochemical studies using an antibody specific for P-protein showed that the observed reduction in the activity of the P-protein in the patient was due to reduction of the catalytic activity of the protein rather than a decrease in the actual amount of the P-protein. Partial inactivation of P-protein could result secondarily from impaired metabolism of glycine, resulting from deficiency in the activity of H-protein. The H-protein from the patient could stimulate the P-protein catalyzed exchange of the carboxyl carbon of glycine with 14CO2, although the specific activity of the purified H-protein from the patient was only 4% of that of control human H-protein. The content of H-protein in the liver of the patient was .apprx. 35% of that of control human liver.